BIO-B
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Focus Partners Wealth | 760 | 0.0% | $211,470 | 0.0% | Held | 2 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 712 | +2.1% | $198,114 | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Wells Fargo & Company/Mn | 170 | 0.0% | $47,303 | 0.0% | Held | 2 | SEC ↗ |
| 4 | UBS Group AG | 13 | +62.5% | $3,617 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 7 holders, 3.78K shares, $776,561 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.